Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus [PDF]
Journal of Diabetes Investigation, 2022 To evaluate whether continuous subcutaneous insulin infusion attenuates the progression of diabetic complications, we retrospectively extracted data from 35 individuals who had developed type 1 diabetes mellitus aged ≤20 years and whose treatment had ...
Takafumi Masuda +8 more
doaj +2 more sources
Continuous subcutaneous insulin infusion: practical issues
Indian Journal of Endocrinology and Metabolism, 2012 The growing number of individuals with diabetes mellitus has prompted new way of treating these patients, continuous subcutaneous insulin infusion (CSII) or insulin pump therapy is an increasingly form of intensive insulin therapy.
Banshi D Saboo, Praful A Talaviya
doaj +3 more sources
Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea [PDF]
Therapeutic Advances in Endocrinology and Metabolism, 2020 A 71-year-old man without previous history of diabetes was hospitalized after suffering polyuria for 1 month and involuntary movement of the left arm for 1 week. His random serum glucose was 42.05 mmol/l and his hemoglobin A1C was 14% (129 mmol/mol). His
Wei Qiang +6 more
doaj +2 more sources
Diabetes remission in newly diagnosed type 2 diabetes mellitus through short‐term continuous subcutaneous insulin infusion intensive therapy combined with low‐carbohydrate diet treatment [PDF]
Journal of Diabetes InvestigationAim/Introduction To evaluate the therapeutic efficacy short‐term continuous subcutaneous insulin infusion (CSII) intensive therapy combined with a low‐carbohydrate diet (LCD) for diabetes remission in patients with newly diagnosed type 2 diabetes ...
Xuemei Huang +12 more
doaj +2 more sources
Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring [PDF]
Neonatal Medicine, 2021 Neonatal diabetes mellitus can be categorized as transient, permanent, or syndromic, and approximately half of the cases are transient. We present a case involving a term newborn who showed overt progression of transient neonatal diabetes mellitus, with ...
Min Soo Kim +9 more
doaj +1 more source
Portuguese Journal of Pediatrics, 2023 Introduction: The incidence of childhood type 1 diabetes is increasing worldwide, especially in young children. According to international guidelines, continuous subcutaneous insulin infusion is the preferred method of insulin delivery for preschool ...
Liliana Teixeira +5 more
doaj +1 more source
Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro
Journal of Diabetes Investigation, 2022 Subcutaneous insulin resistance syndrome is a rare condition that causes difficulty in glycemic control due to severe resistance to subcutaneous insulin injections.
Takahiro Ishii +9 more
doaj +1 more source
Improving the clinical value and utility of CGM systems: issues and recommendations : a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [PDF]
, 2017 The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many then believed CGM would revolutionise the use of intensive insulin therapy in diabetes; however, progress towards that vision has been gradual.
Bergenstal, Richard M. +5 more
core +4 more sources
Use of long-term microdialysis subcutaneous glucose monitoring in the management of neonatal diabetes - A first case report [PDF]
, 2006 In neonatal diabetes mellitus (NDM), a rare genetic disorder, insulin therapy is required but the management is difficult. Frequent blood glucose determinations are necessary in most cases. Microdialysis subcutaneous glucose monitoring (MSGM) is feasible
Andreas Holzinger +13 more
core +1 more source